January 2024
1. CHEN Z, Zha L, Hu B, Xu B, et al
   Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
   Can Respir J. 2024;2024:6038771.
   

   >> Share

   
   
2. OHAR JA, Mahler DA, Davis GN, Lombardi DA, et al
   Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.
   Can Respir J. 2024;2024:8034923.
   

   >> Share

   
   January 2023
3. WANG M, Zhao F, Sun L, Liang Y, et al
   High-Flow Nasal Cannula versus Noninvasive Ventilation in AECOPD Patients with Respiratory Acidosis: A Retrospective Propensity Score-Matched Study.
   Can Respir J. 2023;2023:6377441.
   

   >> Share

   
   
4. KIANI A, Rahimi F, Afaghi S, Paat M, et al
   Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
   Can Respir J. 2023;2023:8678702.
   

   >> Share

   
   
5. WANG Y, Wang L, Chen C, Que Y, et al
   Safety and Risk Factors of Needle Thoracentesis Decompression in Tension Pneumothorax in Patients over 75 Years Old.
   Can Respir J. 2023;2023:2602988.
   

   >> Share

   
   
6. FANG C, Kang B, Zhao P, Ran J, et al
   MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease.
   Can Respir J. 2023;2023:8659293.
   

   >> Share

   
   
7. KOMURA M, Sato T, Suzuki Y, Yoshikawa H, et al
   Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting.
   Can Respir J. 2023;2023:3302405.
   

   >> Share

   
   
8. DU Y, Zhang H, Ma Z, Liu J, et al
   High-Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Randomized Controlled Trials.
   Can Respir J. 2023;2023:7707010.
   

   >> Share

   
   
9. MIAO Y, Wei L, Chen H, Zhang Z, et al
   The Effects of Nebulized Inhaled Triptolide on Airway Inflammation in a Mouse Model of Asthma.
   Can Respir J. 2023;2023:2983092.
   

   >> Share

   
   
10. MALDONADO-FRANCO A, Giraldo-Cadavid LF, Tuta-Quintero E, Bastidas Goyes AR, et al
    The Challenges of Spirometric Diagnosis of COPD.
    Can Respir J. 2023;2023:6991493.
    

    >> Share

    
    
11. KRISHNAN A, Ellis P, Antoine-Pitterson P, Oakes A, et al
    Long-Term Mortality following Acute Noninvasive Ventilation for Obesity-Related Respiratory Failure: A Retrospective Single-Centre Study.
    Can Respir J. 2023;2023:5370197.
    

    >> Share

    
    
12. JEN R, Ellis C, Kaminska M, Road J, et al
    Noninvasive Home Mechanical Ventilation for Stable Hypercapnic COPD: A Clinical Respiratory Review from Canadian Perspectives.
    Can Respir J. 2023;2023:8691539.
    

    >> Share

    
    
13. BASTIDAS AR, Tuta-Quintero E, Arias JS, Cufino D, et al
    Comparison of the Diagnostic Performance of Five Clinical Questionnaires for Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2023;2023:2821056.
    

    >> Share

    
    
14. HE H, Ji X, Cao L, Wang Z, et al
    Medicine Targeting Epithelial-Mesenchymal Transition to Treat Airway Remodeling and Pulmonary Fibrosis Progression.
    Can Respir J. 2023;2023:3291957.
    

    >> Share

    
    January 2022
15. OZYURT S, Ozcelik N, Kara BY, Arpa M, et al
    Evaluation of Thiol/Disulfide Homeostasis in Bronchiectasis.
    Can Respir J. 2022;2022:8340450.
    

    >> Share

    
    
16. LEE JU, Jeong JY, Kim MK, Min SA, et al
    Association of GSTM1 and GSTT1 Null Genotypes with Toluene Diisocyanate-Induced Asthma.
    Can Respir J. 2022;2022:7977937.
    

    >> Share

    
    
17. ZHANG K, Zou X, Ma Z, Liu X, et al
    Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis.
    Can Respir J. 2022;2022:8175508.
    

    >> Share

    
    
18. CAI CS, Wang J
    Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients.
    Can Respir J. 2022;2022:8369521.
    

    >> Share

    
    
19. MOU S, Zhang W, Deng Y, Tang Z, et al
    Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients.
    Can Respir J. 2022;2022:7609083.
    

    >> Share

    
    
20. IZHAKIAN S, Harper E, Gorelik O, Frajman A, et al
    Carboxyhemoglobin Does Not Predict the Need of Mechanical Ventilation and Prognosis during COPD Exacerbation.
    Can Respir J. 2022;2022:6689805.
    

    >> Share

    
    
21. LIU H, Li Y, Zhang X, Shi M, et al
    Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
    Can Respir J. 2022;2022:8509396.
    

    >> Share

    
    
22. ZENG Z, Liu Q, Huang X, Lu C, et al
    Prognostic Role of Chronic Obstructive Pulmonary Disease and Asthma Physiology Score for in-Hospital and 1-year Mortality in Patients with Acute Exacerbations of COPD.
    Can Respir J. 2022;2022:4110562.
    

    >> Share

    
    
23. LIU C, Ran R, Li X, Liu G, et al
    Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.
    Can Respir J. 2022;2022:3982335.
    

    >> Share

    
    
24. QIU Y, Wang Y, Shen N, Wang Q, et al
    Nomograms for Predicting Coexisting Cardiovascular Disease and Prognosis in Chronic Obstructive Pulmonary Disease: A Study Based on NHANES Data.
    Can Respir J. 2022;2022:5618376.
    

    >> Share

    
    
25. ZHAO S, Zheng L, Zhu M, Shui Y, et al
    Intensive Intervention Improves Outcomes for Chronic Obstructive Pulmonary Disease Patients: A Medical Consortium-Based Management.
    Can Respir J. 2022;2022:6748330.
    

    >> Share

    
    
26. DING Q, Mi BB, Wei X, Li J, et al
    Small Airway Dysfunction in Chronic Bronchitis with Preserved Pulmonary Function.
    Can Respir J. 2022;2022:4201786.
    

    >> Share

    
    
27. GONG Y, Lin C, Jin Y, Chen R, et al
    The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2022;2022:2878648.
    

    >> Share

    
    
28. SUN D, Lin R, Ouyang Y
    The Role of CD40, CD86, and Glutathione S-Transferase Omega 1 in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2022;2022:6810745.
    

    >> Share

    
    
29. YAN F, Hu X, He L, Jiao K, et al
    ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway.
    Can Respir J. 2022;2022:8437348.
    

    >> Share

    
    
30. DORSCHEID DR, Lee JK, Ramesh W, Greenwald M, et al
    Guidance for Administering Biologics for Severe Asthma and Allergic Conditions.
    Can Respir J. 2022;2022:9355606.
    

    >> Share

    
    
31. LV C, Liao G, Wu L, Li J, et al
    Effects of Different Intervention Factors on Vascular Endothelial Growth Factor-Induced Human Airway Smooth Muscle Cell Migration.
    Can Respir J. 2022;2022:6879539.
    

    >> Share

    
    
32. ROLO SILVESTRE C, Dias Domingues T, Mateus L, Cavaco M, et al
    The Nutritional Status of Chronic Obstructive Pulmonary Disease Exacerbators.
    Can Respir J. 2022;2022:3101486.
    

    >> Share

    
    
33. LUO JY, Chen HA, Feng YY, Chen YP, et al
    Blood Eosinophil Endotypes across Asthma and Chronic Obstructive Pulmonary Disease (COPD).
    Can Respir J. 2022;2022:9656278.
    

    >> Share

    
    
34. FANG L, Wang X, Zhang M, Khan P, et al
    MicroRNA-101-3p Suppresses mTOR and Causes Mitochondrial Fragmentation and Cell Degeneration in COPD.
    Can Respir J. 2022;2022:5933324.
    

    >> Share

    
    
35. YUAN JY, Wang XY, Tong ZY, Dong YC, et al
    Promising Therapeutic Functions of Bone Marrow Mesenchymal Stem Cells Derived-Exosome in Asthma.
    Can Respir J. 2022;2022:1485719.
    

    >> Share

    
    January 2021
36. XU W, Zhao R, Yuan B
    The Therapeutic Effect of Traditional LiuJunZi Decoction on Ovalbumin-Induced Asthma in Balb/C Mice.
    Can Respir J. 2021;2021:6406295.
    

    >> Share

    
    
37. DING Q, Wei X, Li J, Gao YZ, et al
    Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:9996305.
    

    >> Share

    
    
38. BEUTE J, Boermans P, KleinJan A
    Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.
    Can Respir J. 2021;2021:7456208.
    

    >> Share

    
    
39. CHU S, Ma L, Wei J, Wang J, et al
    Smoking Status Modifies the Relationship between Th2 Biomarkers and Small Airway Obstruction in Asthma.
    Can Respir J. 2021;2021:1918518.
    

    >> Share

    
    
40. SIDLETSKAYA KA, Vitkina TI, Denisenko YK, Mineeva EE, et al
    Role of Toll-Like Receptor 2 in Regulation of T-Helper Immune Response in Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:5596095.
    

    >> Share

    
    
41. JU Y, Ma X, Li H, Liu S, et al
    Relationship between Air Pollution and Hospital Admissions for Chronic Obstructive Pulmonary Disease in Changchun, China: A Season-Stratified Case-Cross Study.
    Can Respir J. 2021;2021:3240785.
    

    >> Share

    
    
42. GAN Q, Tang D, Yan Q, Chen J, et al
    Differential Expression Study of Lysine Crotonylation and Proteome for Chronic Obstructive Pulmonary Disease Combined with Type II Respiratory Failure.
    Can Respir J. 2021;2021:6652297.
    

    >> Share

    
    
43. GOURGOULIANIS K, Ruggieri A, Del Vecchio A, Calisti F, et al
    Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Alpha Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice-The "AIOLOS" Study.
    Can Respir J. 2021;2021:6620585.
    

    >> Share

    
    
44. DAVE C, Wharton S, Mukherjee R, Faqihi BM, et al
    Development and Relevance of Hypercapnia in COPD.
    Can Respir J. 2021;2021:6623093.
    

    >> Share

    
    
45. YUN R, Bai Y, Lu Y, Wu X, et al
    How Breathing Exercises Influence on Respiratory Muscles and Quality of Life among Patients with COPD? A Systematic Review and Meta-Analysis.
    Can Respir J. 2021;2021:1904231.
    

    >> Share

    
    
46. ZHAO K, Miles P, Jiang X, Zhou Q, et al
    BCG Vaccination in Early Childhood and Risk of Atopic Disease: A Systematic Review and Meta-Analysis.
    Can Respir J. 2021;2021:5434315.
    

    >> Share

    
    
47. ALJAZEERI J, Sakkat A, Makhdami N, Almusally R, et al
    Blood Eosinophils and Pulmonary Rehabilitation in COPD.
    Can Respir J. 2021;2021:7449527.
    

    >> Share

    
    
48. DING M, Han X, Bai L, Huang S, et al
    Impact of HACOR Score on Noninvasive Ventilation Failure in Non-COPD Patients with Acute-on-Chronic Respiratory Failure.
    Can Respir J. 2021;2021:9960667.
    

    >> Share

    
    
49. YAO X, Wang X, Yuan J, Huang Z, et al
    Benefits Conferred by Peer-Support Nursing Intervention to Pulmonary Function and Quality of Life in Nonsmoking Patients with COPD.
    Can Respir J. 2021;2021:7450979.
    

    >> Share

    
    
50. JIRANGE P, Vaishali K, Sinha MK, Bairapareddy KC, et al
    A Cross-Sectional Study on Balance Deficits and Gait Deviations in COPD Patients.
    Can Respir J. 2021;2021:6675088.
    

    >> Share

    
    
51. FAQIHI BM, Parekh D, Trethewey SP, Morlet J, et al
    Ward-Based Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure Unrelated to Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:4835536.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share